Moreover, treatment with B1R agonists could attenuate melanoma metastasis by inhibiting VCAM-1 expression, indicating the regulatory role of bradykinin and adhesion molecules in the host immune response of tumor cells [76]. The gene discussed is BDKRB1; the disease is melanoma.